John Fraser Marshall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
John Fraser Marshall has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Anthony T. Blikslager
Department of Clinical Sciences North Carolina State University Raleigh North Carolina USA
12 shared publications - Marco Duz
School of Veterinary Medicine and Science, University of Nottingham, Loughborough, United Kingdom
4 shared publications - Tim D. H. Parkin
Bristol Veterinary School University of Bristol Langford UK
3 shared publications H. David Moll
2 shared publicationsHenry W. Jann
Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078
2 shared publicationsSusan G. Bowman
2 shared publications
Latest Publications
- 11 September 2020
- Published by American Society for Engineering Education
- p. 25.93.1-25.93.15
A Professional Internship: Don't Graduate Without One
- 11 September 2020
- Published by American Society for Engineering Education
- p. 25.93.1-25.93.15
A Professional Internship: Don't Graduate Without One
- Open Access
Numerical investigation into fracture resistance of bone following adaptation
Bone adapts in response to its mechanical environment. This evolution of bone density is one of the most important mechanisms for developing fracture resistance. A finite element framework for simulating bone adaptation, commonly called bone remodelling, is presented. This is followed by a novel method to both quantify fracture resistance and to simulate fracture propagation. The authors' previous work on the application of configurational mechanics for modelling fracture is extended to include the influence of heterogeneous bone density distribution. The main advantage of this approach is that configurational forces, and fracture energy release rate, are expressed exclusively in terms of nodal quantities. This approach avoids the need for post-processing and enables a fully implicit formulation for modelling the evolving crack front. In this paper density fields are generated from both (a) bone adaptation analysis and (b) subject-specific geometry and material properties obtained from CT scans. It is shown that, in order to correctly evaluate the configurational forces at the crack front, it is necessary to have a spatially smooth density field with higher regularity than if the field is directly approximated on the finite element mesh. Therefore, discrete density data is approximated as a smooth density field using a Moving Weighted Least Squares method. Performance of the framework is demonstrated using numerical simulations for bone adaptation and subsequent crack propagation, including consideration of an equine 3rd metacarpal bone. The degree of bone adaption is shown to influence both fracture resistance and the resulting crack path.
Open AccessNumerical investigation into fracture resistance of bone following adaptation
Bone adapts in response to its mechanical environment. This evolution of bone density is one of the most important mechanisms for developing fracture resistance. A finite element framework for simulating bone adaptation, commonly called bone remodelling, is presented. This is followed by a novel method to both quantify fracture resistance and to simulate fracture propagation. The authors' previous work on the application of configurational mechanics for modelling fracture is extended to include the influence of heterogeneous bone density distribution. The main advantage of this approach is that configurational forces, and fracture energy release rate, are expressed exclusively in terms of nodal quantities. This approach avoids the need for post-processing and enables a fully implicit formulation for modelling the evolving crack front. In this paper density fields are generated from both (a) bone adaptation analysis and (b) subject-specific geometry and material properties obtained from CT scans. It is shown that, in order to correctly evaluate the configurational forces at the crack front, it is necessary to have a spatially smooth density field with higher regularity than if the field is directly approximated on the finite element mesh. Therefore, discrete density data is approximated as a smooth density field using a Moving Weighted Least Squares method. Performance of the framework is demonstrated using numerical simulations for bone adaptation and subsequent crack propagation, including consideration of an equine 3rd metacarpal bone. The degree of bone adaption is shown to influence both fracture resistance and the resulting crack path.
- 28 September 2018
- Published by Elsevier
- p. 529-536
Principles of Intestinal Injury and Determination of Intestinal Viability
- 28 September 2018
- Published by Elsevier
- p. 529-536
Principles of Intestinal Injury and Determination of Intestinal Viability
- 26 July 2018
- Published by Wiley in Equine Veterinary Journal
- Vol. 51 (2) , 147-153
Proportion of nonsteroidal anti‐inflammatory drug prescription in equine practice
Summary: Background: There is little knowledge of the prescription of nonsteroidal anti‐inflammatory drugs ( NSAID s) and whether their prescription varies between countries. Objective: To describe prescription practices of NSAID s in equids in the United Kingdom ( UK ), United States of America ( USA ) and Canada. Study design: Descriptive observational study. Methods: Free‐text electronic medical records from 141,543 equids from 10 equine practices in the UK , 255,777 equids from 7 equine practices with 20 branches from the USA and 2 practices with 7 branches from Canada were evaluated. A validated text‐mining technique was used to describe the proportion of equids prescribed NSAID s at least once in these countries. The choice of NSAID s in orthopaedic and colic cases was evaluated. Results: The prescription of NSAID s is more common in the USA (42.4%) and Canada (34.2%) than in the UK (28.6%). Phenylbutazone and flunixin meglumine were the drugs mostly prescribed in all countries. While flunixin meglumine was most prescribed with colic cases in all countries, a proportion received phenylbutazone despite this drug being licensed for use only with musculoskeletal disease. Phenylbutazone was the most commonly prescribed drug in cases with orthopaedic disease followed by flunixin meglumine in all countries. Only a small proportion of cases received meloxicam, ketoprofen or firocoxib. Main limitations: The retrospective design might have resulted in an unknown number of incomplete records, particularly in the reporting of colic and orthopaedic disease. Although the data set is large, the relatively small number of practices recruited from each country may introduce bias. Conclusions: Clinical practice can differ between countries although the influence of individual practitioners and practice‐specific policy on apparent intercountry differences requires further research. Despite several other NSAID s being available and a substantial effort being made to evaluate their efficacy, the prescription of NSAID s other than phenylbutazone and flunixin meglumine remains rather limited.
- 26 July 2018
- Published by Wiley in Equine Veterinary Journal
- Vol. 51 (2) , 147-153
Proportion of nonsteroidal anti‐inflammatory drug prescription in equine practice
Summary: Background: There is little knowledge of the prescription of nonsteroidal anti‐inflammatory drugs ( NSAID s) and whether their prescription varies between countries. Objective: To describe prescription practices of NSAID s in equids in the United Kingdom ( UK ), United States of America ( USA ) and Canada. Study design: Descriptive observational study. Methods: Free‐text electronic medical records from 141,543 equids from 10 equine practices in the UK , 255,777 equids from 7 equine practices with 20 branches from the USA and 2 practices with 7 branches from Canada were evaluated. A validated text‐mining technique was used to describe the proportion of equids prescribed NSAID s at least once in these countries. The choice of NSAID s in orthopaedic and colic cases was evaluated. Results: The prescription of NSAID s is more common in the USA (42.4%) and Canada (34.2%) than in the UK (28.6%). Phenylbutazone and flunixin meglumine were the drugs mostly prescribed in all countries. While flunixin meglumine was most prescribed with colic cases in all countries, a proportion received phenylbutazone despite this drug being licensed for use only with musculoskeletal disease. Phenylbutazone was the most commonly prescribed drug in cases with orthopaedic disease followed by flunixin meglumine in all countries. Only a small proportion of cases received meloxicam, ketoprofen or firocoxib. Main limitations: The retrospective design might have resulted in an unknown number of incomplete records, particularly in the reporting of colic and orthopaedic disease. Although the data set is large, the relatively small number of practices recruited from each country may introduce bias. Conclusions: Clinical practice can differ between countries although the influence of individual practitioners and practice‐specific policy on apparent intercountry differences requires further research. Despite several other NSAID s being available and a substantial effort being made to evaluate their efficacy, the prescription of NSAID s other than phenylbutazone and flunixin meglumine remains rather limited.
- Open Access
- 29 June 2017
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 5 (2) , e17
Validation of an Improved Computer-Assisted Technique for Mining Free-Text Electronic Medical Records
Clinical informatics, decision support for health professionals, electronic health records, and ehealth infrastructures.
- 29 June 2017
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 5 (2) , e17
Open AccessValidation of an Improved Computer-Assisted Technique for Mining Free-Text Electronic Medical Records
Clinical informatics, decision support for health professionals, electronic health records, and ehealth infrastructures.
- Open Access
- 1 September 2016
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 131, 137-145
Prevalence, survival analysis and multimorbidity of chronic diseases in the general veterinarian-attended horse population of the UK
- 1 September 2016
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 131, 137-145
Open AccessPrevalence, survival analysis and multimorbidity of chronic diseases in the general veterinarian-attended horse population of the UK
- 1 May 2015
- Published by Elsevier in The Veterinary Journal
- Vol. 204 (2) , 208-213
Naturally-occurring forelimb lameness in the horse results in significant compensatory load redistribution during trotting
- 1 May 2015
- Published by Elsevier in The Veterinary Journal
- Vol. 204 (2) , 208-213
Naturally-occurring forelimb lameness in the horse results in significant compensatory load redistribution during trotting
- 1 March 2015
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 76 (3) , 208-215
Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery
OBJECTIVE To evaluate ex vivo cyclooxygenase (COX) inhibition and compare in vitro and ex vivo COX-1 inhibition by flunixin meglumine and firocoxib in horses. ANIMALS 4 healthy horses for in vitro experiments and 12 healthy horses (6 males and 6 females; 5 Thoroughbreds, 5 Warmbloods, and 2 ponies) undergoing elective surgery for ex vivo experiments. PROCEDURES 12 horses received flunixin meglumine (1.1 mg/kg, IV, q 12 h) or firocoxib (0.09 mg/kg, IV, q 24 h). Blood samples were collected before (baseline) and 2 and 24 hours after NSAID administration. Prostanoids (thromboxane B 2 , prostaglandin E 2 , and prostaglandin E metabolites) served as indicators of COX activity, and serum drug concentrations were measured by use of high-performance liquid chromatography. An in vitro coagulation-induced thromboxane B 2 assay was used to calculate drug concentration-COX-1 inhibition curves. Effect of time and treatment on COX activity was determined. Agreement between in vitro and ex vivo measurement of COX activity was assessed with Bland-Altman analysis. RESULTS At 2 and 24 hours after NSAID administration, COX-1 activity was reduced, compared with baseline activity, for the flunixin meglumine group only and relative COX-1 activity was significantly greater for the firocoxib group, compared with that for the flunixin meglumine group. There was no significant change in COX-2 activity after surgery for either group. Bland-Altman analysis revealed poor agreement between in vitro and ex vivo measurement of COX-1 activity. CONCLUSIONS AND CLINICAL RELEVANCE Compared with flunixin meglumine, firocoxib had COX-1-sparing effects ex vivo in equine patients that underwent elective surgery.
- 1 March 2015
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 76 (3) , 208-215
Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery
OBJECTIVE To evaluate ex vivo cyclooxygenase (COX) inhibition and compare in vitro and ex vivo COX-1 inhibition by flunixin meglumine and firocoxib in horses. ANIMALS 4 healthy horses for in vitro experiments and 12 healthy horses (6 males and 6 females; 5 Thoroughbreds, 5 Warmbloods, and 2 ponies) undergoing elective surgery for ex vivo experiments. PROCEDURES 12 horses received flunixin meglumine (1.1 mg/kg, IV, q 12 h) or firocoxib (0.09 mg/kg, IV, q 24 h). Blood samples were collected before (baseline) and 2 and 24 hours after NSAID administration. Prostanoids (thromboxane B 2 , prostaglandin E 2 , and prostaglandin E metabolites) served as indicators of COX activity, and serum drug concentrations were measured by use of high-performance liquid chromatography. An in vitro coagulation-induced thromboxane B 2 assay was used to calculate drug concentration-COX-1 inhibition curves. Effect of time and treatment on COX activity was determined. Agreement between in vitro and ex vivo measurement of COX activity was assessed with Bland-Altman analysis. RESULTS At 2 and 24 hours after NSAID administration, COX-1 activity was reduced, compared with baseline activity, for the flunixin meglumine group only and relative COX-1 activity was significantly greater for the firocoxib group, compared with that for the flunixin meglumine group. There was no significant change in COX-2 activity after surgery for either group. Bland-Altman analysis revealed poor agreement between in vitro and ex vivo measurement of COX-1 activity. CONCLUSIONS AND CLINICAL RELEVANCE Compared with flunixin meglumine, firocoxib had COX-1-sparing effects ex vivo in equine patients that underwent elective surgery.